Kj. Peuhkurinen et al., CHANGES IN MYOCARDIAL-METABOLISM AND TRANSCARDIAC ELECTROLYTES DURINGSIMULATED VENTRICULAR-TACHYCARDIA - EFFECTS OF BETA-ADRENERGIC-BLOCKADE, The American heart journal, 128(1), 1994, pp. 96-105
Myocardial ischemia, electrolyte changes, and fluctuations in autonomi
c tone may play an important role in the presentation of malignant ven
tricular arrhythmias. beta-Adrenoceptor blocking agents have been show
n to decrease the incidence of ventricular fibrillation and sudden car
diac death in patients with coronary artery disease. Therefore we inve
stigated the changes in myocardial metabolism and transcardiac electro
lytes during simulated ventricular tachycardia before and after beta-a
drenergic blockade. Six patients with normal coronary arteries (group
1) and 12 patients with documented coronary artery disease (group 2) w
ere included in the study. The right ventricle was paced with electrod
e catheters to a constant cycle length of 400 msec for 3 minutes. Bloo
d samples were withdrawn simultaneously from the coronary sinus and fe
moral artery to determine the transcardiac differences in metabolic va
riables and electrolytes before the pacing, at the end of the pacing,
and 2 minutes thereafter. After pacing, the patients were given intrav
enous propranolol (0.15 mg/kg), and the protocol was repeated. Intraar
terial blood pressure and electrocardiogram were monitored continuousl
y. There was a rapid decline of the mean arterial blood pressures afte
r initiation of the pacing in both study groups, whereafter the pressu
res began to rise. Propranolol somewhat blunted the blood pressure rec
overy, especially in group 2. Norepinephrine levels increased during t
he pacing in both patient groups, and, the increase was accentuated by
beta-adrenergic blockade. The femoroarterial coronary sinus differenc
e in lactate turned negative, and pH, PCO2 and potassium differences i
ncreased in group 2 during pacing. However, the myocardial energy stat
e remained relatively good as estimated from the nonsignificant change
in the transcardiac differences of the plasma adenosine catabolites.
There were no changes in the metabolic variables or transcardiac elect
rolytes in group 1 patients during pacing. Propranolol did not prevent
the metabolic ischemia, but it did prevent the pacing-induced decreas
e in coronary sinus potassium and increase in transcardiac potassium d
ifference. Propranolol also decreased arterial levels of free fatty ac
ids and their extraction in group 2 patients during pacing. In conclus
ion, blood pressure decay during simulated ventricular tachycardia is
followed by instantaneous sympathoadrenergic activation. In patients w
ith coronary artery disease, this process is accompanied by metabolic
ischemia and net transfer of extracellular potassium into the intracel
lular space. The metabolic and electrolyte changes may result in alter
ations of electrophysiologic milieau, thereby also modifying the clini
cal characteristics of ventricular tachycardia. Propranolol decreases
arterial levels of free fatty acids and prevents changes in transcardi
ac electrolytes observed in coronary artery disease patients during si
mulated ventricular tachycardia. These effects of propranolol may be o
f clinical significance.